Tag: Predictmedix
-
Leaping Forward: PredictMedix (PMED.C) partners with TechMahindra
Keynes once said that “the market can remain irrational longer than you can remain solvent”. Fundamentals departed market valuation long ago, but you could’ve at least expected market reaction to be in response to COVID-19 related news. Except it seems like that’s no longer the case.
-
Predictmedix (PMED.C) inks deal to acquire a Telehealth company
Predictmedix and MobileWellbeing are attacking the Telehealth problem from different angles.
-
![Predictmedix (PMED.C) killing it on new COVID-19 screening tech]()
Predictmedix (PMED.C) killing it on new COVID-19 screening tech
I love it when a plan comes together. Predictmedix (PMED.C) continued to launch itself upward this week, jumping from $0.72 to $0.98 in just days, on the back of news it’s being used by a large events company, and financials that show a very short road to profitability. For those that haven’t been paying attention…
-
Everything is up: Eat, drink, be merry… for tomorrow we die
When the history books are written on this passage of our lives, under pandemic lockdown and with once-in-three-generations levels of unemployment, they’ll note that in order to save us from economic collapse, the government printed trillions of dollars and just fired it all into the markets out of a bazooka, only to establish a decades-long…
-
![Predictmedix (PMED.C) inks deal to install COVID-19 Mass Screening Tech]()
Predictmedix (PMED.C) inks deal to install COVID-19 Mass Screening Tech
“Predictmedix’ best-in-class screening technology pairs perfectly with our ability to custom-fabricate quickly and efficiently,” states Jonathan Auger, CEO of Juiceworks Exhibits
-
![PredictMedix: Pharma Monopoly Meets Tech Growth]()
PredictMedix: Pharma Monopoly Meets Tech Growth
Here’s a simple and effective investment strategy: invest in companies that sell products with growing inelastic demand.
-
Predictmedix (PMED.C) bursts out of the starting blocks with 3 big alliances
Two weeks ago, Predictmedix filed a Patent Application in the U.S. for its AI-driven rapid screening system for infectious diseases.
